Literature DB >> 23364513

Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.

Michael Schomaker1, Matthias Egger, Mhairi Maskew, Daniela Garone, Hans Prozesky, Christopher J Hoffmann, Andrew Boulle, Lukas Fenner.   

Abstract

We studied the immune response after starting antiretroviral treatment (ART) in 15,646 HIV-infected patients with or without tuberculosis (TB) at presentation in 3 ART programs in South Africa between 2003 and 2010. Patients presenting with TB had similar increases in CD4 cells compared with all other patients (adjusted difference 4.9 cells/µL per 6 months, 95% confidence interval: 0.2 to 9.7). Younger age, advanced clinical stage, female sex, and lower CD4 cell count at ART start were all associated with steeper CD4 slopes. In South Africa, HIV-infected patients presenting with TB experience immune recovery after starting ART that is no worse than in other patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23364513      PMCID: PMC3671097          DOI: 10.1097/QAI.0b013e318288b39d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

Review 1.  AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection.

Authors:  S D Lawn
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

2.  Tuberculosis in HIV programmes in lower-income countries: practices and risk factors.

Authors:  L Fenner; M Forster; A Boulle; S Phiri; P Braitstein; C Lewden; M Schechter; N Kumarasamy; M Pascoe; E Sprinz; D R Bangsberg; P S Sow; D Dickinson; M P Fox; J McIntyre; M Khongphatthanayothin; F Dabis; M W G Brinkhof; R Wood; M Egger
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

3.  Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

Authors:  Matthias Egger; Didier K Ekouevi; Carolyn Williams; Rita Elias Lyamuya; Henri Mukumbi; Paula Braitstein; Tyler Hartwell; Claire Graber; Benjamin H Chi; Andrew Boulle; François Dabis; Kara Wools-Kaloustian
Journal:  Int J Epidemiol       Date:  2011-05-18       Impact factor: 7.196

4.  Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.

Authors:  Eric Balestre; Serge P Eholié; Amani Lokossue; Papa Salif Sow; Man Charurat; Albert Minga; Joseph Drabo; François Dabis; Didier K Ekouevi; Rodolphe Thiébaut
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

Review 5.  Update on the epidemiology and transmission of Pneumocystis carinii.

Authors:  Alison Morris; C Ben Beard; Laurence Huang
Journal:  Microbes Infect       Date:  2002-01       Impact factor: 2.700

6.  Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.

Authors:  Antonella Cingolani; Alessandro Cozzi Lepri; Antonella Castagna; Delia Goletti; Andrea De Luca; Paolo Scarpellini; Iuri Fanti; Andrea Antinori; Antonella d'Arminio Monforte; Enrico Girardi
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

7.  Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.

Authors:  S D Lawn; R J Shattock; J W Acheampong; R B Lal; T M Folks; G E Griffin; S T Butera
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

8.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

9.  Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Authors:  Christina L Lancioni; C Scott Mahan; Denise F Johnson; Maria Walusimbi; Keith A Chervenak; Sophie Nalukwago; Edwin Charlebois; Diane Havlir; Harriet Mayanja-Kizza; Christopher C Whalen; W Henry Boom
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

10.  Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.

Authors:  Lynn Morris; Desmond J Martin; Helba Bredell; Stephina N Nyoka; Leonard Sacks; Stella Pendle; Liesl Page-Shipp; Christopher L Karp; Timothy R Sterling; Thomas C Quinn; Richard E Chaisson
Journal:  J Infect Dis       Date:  2003-06-04       Impact factor: 5.226

View more
  7 in total

Review 1.  The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review.

Authors:  Heidi M Soeters; Sonia Napravnik; Monita R Patel; Joseph J Eron; Annelies Van Rie
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

2.  Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy.

Authors:  Amara E Ezeamama; Ezekiel Mupere; James Oloya; Leonardo Martinez; Robert Kakaire; Xiaoping Yin; Juliet N Sekandi; Christopher C Whalen
Journal:  Int J Infect Dis       Date:  2015-04-21       Impact factor: 3.623

3.  Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.

Authors:  Damalie Nakanjako; Agnes N Kiragga; Beverly S Musick; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Lameck Diero; Patrick Oyaro; Emanuel Lugina; John C Ssali; Andrew Kambugu; Philippa Easterbrook
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

4.  Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.

Authors:  Kathrin Zürcher; Marcel Zwahlen; Marie Ballif; Hans L Rieder; Matthias Egger; Lukas Fenner
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

5.  Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.

Authors:  Alain M Vandormael; David R Boulware; Frank C Tanser; Till W Bärnighausen; Katharine E Stott; Tulio de Oliveira
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

Review 6.  Systematic review of statistically-derived models of immunological response in HIV-infected adults on antiretroviral therapy in Sub-Saharan Africa.

Authors:  Joseph B Sempa; Eva L Ujeneza; Martin Nieuwoudt
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

7.  Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.

Authors:  Geoffrey Fatti; Eula Mothibi; Graeme Meintjes; Ashraf Grimwood
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.